Intrinsic Value of S&P & Nasdaq Contact Us

Orchestra BioMed Holdings, Inc. OBIO NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.00
+166.1%

Stock Statistics — OBIO

Orchestra BioMed Holdings, Inc. (OBIO) has a market capitalization of $263.93M and trades at $4.51. The 52-week range is 2.2-5.424.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.1, Earnings Per Share (EPS) of $-1.11, annual revenue of $33.48M.

The stock has a beta of 0.60, operates in the Healthcare sector.

Trading Data
Current Price$4.51
52-Week Range2.2-5.424
Volume168.05K
Avg Volume (30D)202.61K
Market Cap$263.93M
Beta (1Y)0.60
Company
IPO Date2020-08-04
Employees70
CEODavid Hochman
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS68572M1062
CUSIP68572M106
Income (Latest Year)
Revenue$33.48M
Gross Profit$33.29M
EBITDA$-51.48M
Operating Income$-51.81M
Net Income$-52.96M
EPS$-1.11
EPS Diluted$-1.11
Shares Outstanding$38.39B
Balance Sheet (Latest Year)
Total Assets$114.86M
Current Assets$107.91M
Cash & ST Investments$106.51M
Total Liabilities$51.48M
Total Debt$1.69M
Net Debt$-33M
Total Equity$63.38M
Debt / Equity0.03
Valuation Ratios
P/E Ratio-4.1
P/S Ratio7.88
P/B Ratio4.16
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message